Amyris drops 11%, announces capital structure transformation

seekingalpha2023-06-05

Synthetic biotechnology company, Amyris (NASDAQ:AMRS) Board of Directors will execute on a transformation program to accelerate improvements to the company's cost and capital structure and liquidity. ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1
1